3D BREAST TOMOSYNTHESIS MARKET

INTRODUCTION 3D BREAST TOMOSYNTHESIS MARKET

Tomosynthesis, sometimes known as "3D" mammography, is a novel type of digital x-ray mammogram that generates 2D and 3D-like images of the breasts. This technology increases mammography's ability to detect early breast cancers and reduces the proportion of women "called back" for extra tests for findings that are not malignancies.

Breast tomosynthesis, commonly known as 3D mammography, is a technique that uses a succession of two-dimensional images to create a three-dimensional image of the breast.

Standard mammography, which is currently considered the most reliable method for breast cancer screenings, produces 2D images of the breasts.A computer then reconstructs or "synthesises" these digital images into a series of three-dimensional images. 

3D BREAST TOMOSYNTHESIS MARKET SIZE AND FORECAST

The Global 3D Breast Tomosynthesis market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 3D BREAST TOMOSYNTHESIS MARKET NEW PRODUCT LAUNCH

Amrita Hospital in Kochi introduces a novel breast cancer detection system. The distinct contrast-enhanced mammography aids in the detection of cancers that would not be seen on a normal mammogram. A novel mammography machine was unveiled at Amrita Hospital in Kochi, ushering in a new era in breast cancer diagnosis.

The technology provides a contrast-enhanced 50-degree wide-angle view for tomosynthesis and biopsies.  The new technology will allow for faster and more precise stereotactic biopsies. It allows for a reduced examination time for breast cancer diagnosis while also improving patient comfort and convenience, which aids in early detection. It is the first of its sort in Kerala. 

The gadget was introduced as part of the hospital's World Cancer Day festivities, which included patients, clinicians, and representatives of the foundations that work tirelessly to close the cancer care gap. This gadget is the most recent technology for early diagnosis of breast cancer, and it has become widely used during the last decade.This device uses 3D technology to capture photos of a fixed compressed breast from numerous angles during a brief scan.

The individual images are then reassembled into a sequence of thin high-resolution slices that can be seen individually or in dynamic cine-mode. Many exciting opportunities exist with contrast-enhanced 3D imaging and digital breast tomosynthesis, including reducing breast compression, improving diagnostic and screening accuracy, and applying 3D lesion localisation. 

3D BREAST TOMOSYNTHESIS MARKET COMPANY PROFILE

• Hologic, Inc.
• GE Healthcare
• Fujifilm Holdings Corporation
• Siemens Healthineers
• Planmed Oy

THIS 3D BREAST TOMOSYNTHESIS MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many 3D Breast Tomosynthesis are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global 3D Breast Tomosynthesis and key vendor selection criteria
3. Where is the 3D Breast Tomosynthesis manufactured? What is the average margin per unit?
4. Market share of Global 3D Breast Tomosynthesis market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global 3D Breast Tomosynthesis in-house
6. key predictions for next 5 years in Global 3D Breast Tomosynthesis market
7. Average B-2-B 3D Breast Tomosynthesis market price in all segments
8. Latest trends in 3D Breast Tomosynthesis market, by every market segment
9. The market size (both volume and value) of the 3D Breast Tomosynthesis market in 2024-2030 and every year in between?
10. Production breakup of 3D Breast Tomosynthesis market, by suppliers and their OEM relationship